Politics & FDA clearance of 2 stem cell clinic COVID-19 efforts
Politics & FDA clearance of 2 stem cell clinic COVID-19 efforts
The FDA and its CBER branch have been doing a good job overall in the last 3+ years to tackle the unproven stem cell clinic problem, but lately on the stem cells for COVID-19 front there is reason for real concern.
I believe the agency is taking on major risk overall by clearing a vast number of cell therapy trials for COVID-19 mostly without much data, but the clearance of a few programs by…
View On WordPress














